Trabectedin API Suppliers & Bulk Manufacturers
Available Forms: API (drug substance)
Available Strengths: USP grade or in-house specification
Reference Brands: Yondelis
Category: Active Pharmaceutical Ingredient
Trabectedin is a highly potent, marine-derived cytotoxic made by a long semi-synthetic route. It is sourced by oncology injectable manufacturers, CDMOs and R&D teams.
Manufacture or export Trabectedin API? List it or send an offer →
Product Description:
Trabectedin is an alkylating agent first isolated from the sea squirt Ecteinascidia turbinata; it binds in the minor groove of DNA and interferes with transcription and DNA repair, which leads to tumour cell death. In the US it is approved for unresectable or metastatic liposarcoma or leiomyosarcoma after a prior anthracycline-containing regimen. In the EU it is approved for advanced soft tissue sarcoma after anthracyclines and ifosfamide, or where these are unsuitable, and with pegylated liposomal doxorubicin for relapsed platinum-sensitive ovarian cancer (reference brand: Yondelis).
Specification at a glance
| Traded form | Free base; tetrahydroisoquinoline alkaloid made by semi-synthesis and supplied in gram-scale quantities |
|---|---|
| CAS number | 114899-77-3 |
| Molecular formula | C39H43N3O11S |
| Molecular weight | 761.8 g/mol |
| Pharmacopoeia | No Ph. Eur., BP or JP monograph found. Trabectedin was listed by USP for monograph development and its current USP status is unverified; otherwise supplied to an in-house specification. |
Regulatory files and timing
The FDA list of Drug Master Files (third quarter 2026) shows 7 active Type II API DMFs for this molecule. Few filings usually means few qualified sources, so early contact with suppliers pays off. For Europe, ask whether the supplier holds a CEP or an EU ASMF and, for imports into the EU, a written confirmation.
Generic or biosimilar entry. United States: Patent expiry; entry not confirmed (Jan 2028). European Union: No confirmed date (generic authorised Apr 2025).
Handling and quality points
Trabectedin is active at very low exposure levels, so it is handled in the highest containment band, normally in isolators within dedicated or strictly segregated suites with validated cleaning and deactivation. Batches are small and the molecule is sensitive to heat and light, so expect cold storage, light protection and temperature-controlled shipping. Analytical precision matters: assay and related-substance methods have to work well at the low quantities used in the finished lyophilised product.
Send an API enquiry All specialty APIs
Brand names are trademarks of their respective owners and identify the reference medicine only. Information is general and was checked in October 2026; confirm specifications and filings with the supplier before purchase.
Trabectedin API — third party manufacturing & bulk supply
Trabectedin API is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Trabectedin API is supplied as API (drug substance) — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Trabectedin API listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Trabectedin API →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Buyers normally ask for the GMP certificate, a US DMF letter of access or EU ASMF, a full CoA with related substances, and stability data that supports the storage temperature. Given the potency, an occupational exposure assessment and a description of the containment used are also standard requests. Ask for the impurity rationale covering starting materials from the semi-synthetic route.
Expect it to sit in the top occupational exposure band, with limits in the nanogram per cubic metre range. That means closed handling in isolators, dedicated or campaign-segregated equipment and validated cleaning verification. Check the supplier's exposure monitoring data before you plan your own fill-finish line.
Yes. We link licensed manufacturers, CDMOs and research teams with GMP-compliant trabectedin producers that can show suitable high-containment facilities. PharmaTradz checks the documents first, and buyer details are only shared once both sides agree.
Related Products
Ferric Derisomaltose API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Monoferric, Monofer
View DetailsNusinersen Sodium API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Spinraza
View DetailsIvabradine Hydrochloride API
Strength:
Supplied to an in-house or pharmacopoeial specification
Form: API (drug substance)
Reference Brands: Corlanor, Procoralan
View DetailsPonatinib Hydrochloride API
Strength:
USP grade or in-house specification
Form: API (drug substance)
Reference Brands: Iclusig
View DetailsCalcium Dobesilate Granules
Strength:
API Purity: 98% (on anhydrous basis)
Form: Granules/ Powder
Reference Brands:
View DetailsIsavuconazole
Strength:
High-purity API
Form: White to off-white crystalline powder
Reference Brands: Cresemba (US/EU)
View DetailsLevocarnitine API
Strength:
API Purity: 98% (on anhydrous basis) BP / EP / USP Standard
Form: Crystalline powder
Reference Brands: Carnitor (US/EU)
View DetailsDoxepin
Strength:
API Purity: 99% (on anhydrous basis)
Form: White to off-white crystalline powder
Reference Brands: Sinequan, Silenor (US)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit